Effect of dialyzer membranes on mortality in uremic patients undergoing long‐term hemodialysis: A Nationwide population‐based study using the Taiwan Dialysis Registry Data System 2005–2012

The characteristics in dialyzer are associated with mortality in patients with end‐stage renal disease (ESRD) receiving hemodialysis (HD). This study is to investigate the effects of dialyzer membranes on 3‐year mortality in ESRD patients. From the long‐term nationwide population database. Prevalent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Therapeutic apheresis and dialysis 2022-02, Vol.26 (1), p.55-63
Hauptverfasser: Chang, Chih‐Yu, Wu, Mai‐Szu, Chang, Chen‐Hao, Lin, Chih‐Chieh, Lin, Hsiang‐Ling, Kao, Chih‐Chin, Chen, Hsi‐Hsien, Li, Albert, Hsu, Chih‐Cheng, Lin, Yen‐Chung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The characteristics in dialyzer are associated with mortality in patients with end‐stage renal disease (ESRD) receiving hemodialysis (HD). This study is to investigate the effects of dialyzer membranes on 3‐year mortality in ESRD patients. From the long‐term nationwide population database. Prevalent HD patients during 2005–2012 were enrolled. Our main analysis to calculate the effect was cox regression multivariate model. Overall, the mean age of all population (N = 73 565) was 61.0 ± 13.6 years, the observation period is 2.46 years ±0.98 within 3 years and 64.6% used polysulfone (PS), polymethyl methacrylate (PMMA) (11.6%), polyethersulfone (11.4%), and cellulose triacetate (CTA) (10.7%), ethylene vinyl alcohol (EVAL) (hazard ratio [HR] 2.72, 95% confidence interval [CI] 1.71–4.33) and CTA (HR 1.35, 95% CI 1.12–1.64) were associated with higher mortality than PS, but PMMA was not. EVAL and CTA adversely affected mortality and PMMA had no protective role. Further investigations on membrane characters on HD patients are warranted. Taipei Medical University (TMU) (TMU‐JIRB (No. N201804051).
ISSN:1744-9979
1744-9987
DOI:10.1111/1744-9987.13665